{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:52:07Z","timestamp":1792738327800,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.thromres.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T18:51:04Z","timestamp":1521139864000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose"],"prefix":"10.1016","volume":"165","author":[{"given":"Carina","family":"Oedingen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-8829","authenticated-orcid":false,"given":"Stefan","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Razum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.03.005_bb0005","author":"Earth Policy Institute"},{"key":"10.1016\/j.thromres.2018.03.005_bb0010","series-title":"World Contraceptive Patterns 2013","author":"United Nations, Department of Economic and Social Affairs","year":"2013"},{"key":"10.1016\/j.thromres.2018.03.005_bb0015","author":"European Medicines Agency (EMA)"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.005_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.005_bb0025","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","author":"Lawrie","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"28\u201329","key":"10.1016\/j.thromres.2018.03.005_bb0030","first-page":"495","article-title":"Hormonal contraception\u2014what kind, when, and for whom?","volume":"108","author":"Wiegratz","year":"2011","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"10.1016\/j.thromres.2018.03.005_bb0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"8990","key":"10.1016\/j.thromres.2018.03.005_bb0040","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"issue":"8990","key":"10.1016\/j.thromres.2018.03.005_bb0045","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.03.005_bb0050","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2018.03.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2018.03.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.005_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.thromres.2018.03.005_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"issue":"6","key":"10.1016\/j.thromres.2018.03.005_bb0075","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.thromres.2018.03.005_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"issue":"8990","key":"10.1016\/j.thromres.2018.03.005_bb0085","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.thromres.2018.03.005_bb0090","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jth.12224","article-title":"Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?","volume":"11","author":"Bird","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.03.005_bb0095","first-page":"1","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hycklama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2018.03.005_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.03.005_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2018.03.005_bb0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/humupd\/5.6.736","article-title":"The aftermath of a pill scare: regression to reassurance","volume":"5","author":"Spitzer","year":"1999","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.thromres.2018.03.005_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2009.12.014","article-title":"Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10\u202fyears after the third-generation \"pill scare\"","volume":"81","author":"Heinemann","year":"2010","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.thromres.2018.03.005_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"key":"10.1016\/j.thromres.2018.03.005_bb0125","author":"Glaeske"},{"issue":"3","key":"10.1016\/j.thromres.2018.03.005_bb0130","first-page":"191","article-title":"Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.thromres.2018.03.005_bb0135","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7305","key":"10.1016\/j.thromres.2018.03.005_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.005_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13625187.2011.643836","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis","volume":"17","author":"Martinez","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.thromres.2018.03.005_bb0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0b013e318250c3a0","article-title":"Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17\u03b2-estradiol: a randomized controlled trial","volume":"119","author":"Westhoff","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2018.03.005_bb0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.thromres.2018.03.005_bb0160","series-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"issue":"15","key":"10.1016\/j.thromres.2018.03.005_bb0165","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology, a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2018.03.005_bb0170","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.thromres.2018.03.005_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2427\/5937","article-title":"Quality assessment in meta-analysis","volume":"3","author":"La Torre","year":"2006","journal-title":"IJPH"},{"key":"10.1016\/j.thromres.2018.03.005_bb0180","series-title":"Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]","article-title":"Chapter 9: analysing data and undertaking meta-analyses","author":"Deeks","year":"2011"},{"key":"10.1016\/j.thromres.2018.03.005_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.thromres.2018.03.005_bb0190","series-title":"[Computer program] Version 5.3","author":"ReviewManager (RevMan)","year":"2014"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.005_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.159.1.65","article-title":"Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias","volume":"159","author":"Bloemenkamp","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.005_bb0200","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2018.03.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.thromres.2018.03.005_bb0210","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/14.6.1500","article-title":"Venous thromboembolic disease and combined oral contraceptives: a re-analysis of the MediPlus database","volume":"14","author":"Todd","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.thromres.2018.03.005_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.thromres.2018.03.005_bb0220","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"issue":"9173","key":"10.1016\/j.thromres.2018.03.005_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptives","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.03.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"issue":"Sup2","key":"10.1016\/j.thromres.2018.03.005_bb0235","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.3109\/13625187.2010.533002","article-title":"Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries","volume":"15","author":"Skouby","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.thromres.2018.03.005_bb0240","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.thromres.2018.03.005_bb0245","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.005_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestogens: role of bias in observational research, the transnational research group on oral contraceptives and the health of young woman","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818302743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818302743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T01:42:27Z","timestamp":1719884547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818302743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":50,"alternative-id":["S0049384818302743"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.03.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}